182 related articles for article (PubMed ID: 9756183)
1. The role of theophylline and phosphodiesterase4 isoenzyme inhibitors as anti-inflammatory drugs.
Spina D; Landells LJ; Page CP
Clin Exp Allergy; 1998 Aug; 28 Suppl 3():24-34. PubMed ID: 9756183
[TBL] [Abstract][Full Text] [Related]
2. The potential of PDE4 inhibitors in asthma or COPD.
Spina D
Curr Opin Investig Drugs; 2000 Oct; 1(2):204-13. PubMed ID: 11249575
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
4. Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma.
Banner KH; Page CP
Eur Respir J; 1995 Jun; 8(6):996-1000. PubMed ID: 7589387
[TBL] [Abstract][Full Text] [Related]
5. Are phosphodiesterase 4 inhibitors just more theophylline?
Boswell-Smith V; Cazzola M; Page CP
J Allergy Clin Immunol; 2006 Jun; 117(6):1237-43. PubMed ID: 16750981
[TBL] [Abstract][Full Text] [Related]
6. Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors.
Lagente V; Hichami A; Boichot E; Martins MA; Silva PM
Allerg Immunol (Paris); 1995 Feb; 27(2):34-9. PubMed ID: 7710653
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
Dastidar SG; Rajagopal D; Ray A
Curr Opin Investig Drugs; 2007 May; 8(5):364-72. PubMed ID: 17520865
[TBL] [Abstract][Full Text] [Related]
8. Theophylline and airway inflammation.
Rabe KF; Dent G
Clin Exp Allergy; 1998 Aug; 28 Suppl 3():35-41. PubMed ID: 9756184
[TBL] [Abstract][Full Text] [Related]
9. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation.
Smith VB; Spina D
Curr Opin Investig Drugs; 2005 Nov; 6(11):1136-41. PubMed ID: 16312135
[TBL] [Abstract][Full Text] [Related]
10. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.
Sanz MJ; Cortijo J; Morcillo EJ
Pharmacol Ther; 2005 Jun; 106(3):269-97. PubMed ID: 15922015
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents.
Doherty AM
Curr Opin Chem Biol; 1999 Aug; 3(4):466-73. PubMed ID: 10419856
[TBL] [Abstract][Full Text] [Related]
12. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
13. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.
Manning CD; Burman M; Christensen SB; Cieslinski LB; Essayan DM; Grous M; Torphy TJ; Barnette MS
Br J Pharmacol; 1999 Dec; 128(7):1393-8. PubMed ID: 10602317
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase inhibitors.
Boswell-Smith V; Spina D; Page CP
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S252-7. PubMed ID: 16402111
[TBL] [Abstract][Full Text] [Related]
15. Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
Harada D; Tsukumo Y; Takashima Y; Manabe H
Eur J Pharmacol; 2006 Feb; 532(1-2):128-37. PubMed ID: 16442096
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
Chan SC; Hanifin JM
J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
[TBL] [Abstract][Full Text] [Related]
17. [Theophylline--anti-inflammatory drug].
Chazan R
Pol Merkur Lekarski; 1998 Feb; 4(20):61-5. PubMed ID: 9591435
[TBL] [Abstract][Full Text] [Related]
18. CC-10004 .
Khobzaoui M; Gutke HJ; Burnet M
Curr Opin Investig Drugs; 2005 May; 6(5):518-25. PubMed ID: 15912967
[TBL] [Abstract][Full Text] [Related]
19. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor.
Karish SB; Gagnon JM
Ann Pharmacother; 2006 Jun; 40(6):1096-104. PubMed ID: 16735669
[TBL] [Abstract][Full Text] [Related]
20. The potential of phosphodiesterase 4 inhibitors for the treatment of depression: opportunities and challenges.
Renau TE
Curr Opin Investig Drugs; 2004 Jan; 5(1):34-9. PubMed ID: 14983971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
